Jonathan C Javitt insider trades
Open-market stock purchases and sales by Jonathan C Javitt, Chairman and Chief Scientist at NRX Pharmaceuticals, Inc, from SEC Form 4 filings since May 24, 2021.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- NRXP NRX Pharmaceuticals, Inc: 5 buys, 1 sale, last Apr 9, 2025